IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2015 Holdings

Filed 2016-02-17 | 21 holdings | $1.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$921.0K135,80058.1%
Champions Oncology Inc(CSBR)COMM NEW15870P307$397.0K111,11125.0%
Medivation, Inc.COM58501N101$212.6K4,397,83813.4%
Ampio Pharmaceuticals Inc.COM03209T109$11.9K3,388,3220.7%
Synthetic Biologics Inc.COM87164U102$8.6K3,734,1490.5%
Alcobra LtdSHSM2239P109$7.0K1,115,3150.4%
Cempra IncCOM15130J109$5.6K180,8000.4%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$4.6K1,359,7670.3%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$4.2K2,563,9250.3%
Newlink Genetics CorpCOM651511107$3.7K102,4370.2%
Advaxis Inc.COM NEW007624208$2.8K275,0000.2%
Vascular Biologics LTDCOM96883109$1.8K333,3320.1%
Bio Blast Pharma LtdSHSM20156101$1.3K338,1100.1%
OHR Pharmaceutical IncCOM NEW67778H200$1.3K205,0000.1%
Keryx Biopharmaceuticals Inc.COM492515101$1.0K200,0000.1%
Advaxis Inc.W EXP 07/15/201007624117$798112,5000.1%
Caladrius Biosciences IncCOM128058104$600555,7810.0%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$49565,0000.0%
Evoke Pharma IncCOM30049G104$18455,6600.0%
Zosano Pharma CorpCOM98979H103$4218,6000.0%
Aptose Biosciences IncCOM NEW03835T200$3111,9330.0%